Specifically, hyperglycemia causes metabolic and epigenetic changes via the MLL pathway in BMDMs, while the uremic toxin IS induces metabolic reprogramming and epigenetic modifications via the AhR pathway21. Here, KMT2A is linked to Hyperglycemia.